KalshiOpen
Medtronic cardiovascular growth in Q2: Will Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?
No55%
Above 11%45%
Price checked at
Trade
Set your country to see where you can trade.Set your country →
Opens the venue in a new tab, through Predxy.24h volume$0
7d volume—
30d volume—
Liquidity—
Spread10%
ResolvesMar 31, 2027in 6 months
Probability history
Market-implied probabilities · All recorded historyDrag to move · pinch or ⌘/Ctrl+scroll to zoom
Shaded periods have no successful hourly price check.
Based on this market’s outcome prices, expressed as probabilities.
Resolution rules
If Medtronic plc reports Above 11% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names are the property of their respective owners.
Other legs of this event
A leg read alone is misleading; the others are beside it.Venue activity
Read from the venue this minuteHolders—
Held value—
Trades (24h)—
Trades—
Open interest—
Comments0
Discussion on Predxy
What Predxy's readers make of this market. Everyone can read; signed-in readers can write. The venue's own thread, when it has one, is the box below.Sign in to join the discussion.
Nobody has said anything here yet.
As of Sep 30, 02:16 AM UTC